Aimco Pesticides is currently trading at Rs. 108.00, up by 17.10 points or 18.81% from its previous closing of Rs. 90.90 on the BSE.
The scrip opened at Rs. 109.05 and has touched a high and low of Rs. 109.05 and Rs. 103.55 respectively. So far 108468 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 119.50 on 04-Jan-2021 and a 52 week low of Rs. 45.70 on 22-May-2020.
Last one week high and low of the scrip stood at Rs. 109.05 and Rs. 84.10 respectively. The current market cap of the company is Rs. 102.05 crore.
The promoters holding in the company stood at 51.35%, while Institutions and Non-Institutions held 0.08% and 48.58% respectively.
Aimco Pesticides has executed a 3 year contract manufacturing agreement for one of its existing product with an Indian agrochemical major (hereinafter referred as Customer).
The contract entails a 3-year supply agreement with the Customer commencing 1st April 2021, for one of the company’s existing Technical product. The company expects production to fully-stabilize by June 2021, during which production will ramp-up to the desired levels. Over the tenure of the contract, the company expects to generate revenues of approximately Rs 225-250 crore. The company has already incurred a capital outlay of Rs 5 crore and further investment of Rs 10 crore in plant & machinery, debottlenecking, utility & safety, effluent treatment facility, and warehousing is expected in FY2021-22.
Aimco Pesticides manufactures a large array of high quality technical grade pesticides, fungicides, herbicides and other chemicals that aids the cultivator to attain the optimum farm yields them so desires.
| Company Name | CMP |
|---|---|
| UPL | 656.15 |
| PI Industries | 3036.95 |
| Bayer CropScience | 4852.90 |
| Sharda Cropchem | 1101.50 |
| Sumitomo Chemical | 446.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: